-
Ab176456-100μgApamistamab (anti-PTPRC) is an anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab176456-10mgApamistamab (anti-PTPRC) is an anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab176456-1mgApamistamab (anti-PTPRC) is an anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab176456-5mgApamistamab (anti-PTPRC) is an anti-CD45 monoclonal antibody (MoAb) with immunotherapeutic activity.Purity>95% (SDS-PAGE&SEC)Endotoxin Level< 1.0EU/mg
-
Ab090177-100μlRabbit anti Human ATP6V1D Antibody, Polyclonal, could be used for WB, IHC and so on.Application:WB: 1/500-1/4000IHC: 1/50-1/100Protein FunctionRelevance': "ATP6V1D is a subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is an
-
Ab090177-10μlRabbit anti Human ATP6V1D Antibody, Polyclonal, could be used for WB, IHC and so on.Application:WB: 1/500-1/4000IHC: 1/50-1/100Protein FunctionRelevance': "ATP6V1D is a subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is an
-
Ab090177-1mlRabbit anti Human ATP6V1D Antibody, Polyclonal, could be used for WB, IHC and so on.Application:WB: 1/500-1/4000IHC: 1/50-1/100Protein FunctionRelevance': "ATP6V1D is a subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is an
-
Ab090177-50μlRabbit anti Human ATP6V1D Antibody, Polyclonal, could be used for WB, IHC and so on.Application:WB: 1/500-1/4000IHC: 1/50-1/100Protein FunctionRelevance': "ATP6V1D is a subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is an
-
Ab175976-10mgBALB/c Mouse IgG Antibody Isotype Control Antibody
-
Ab175976-1mgBALB/c Mouse IgG Antibody Isotype Control Antibody
-
Ab175976-2mgBALB/c Mouse IgG Antibody Isotype Control Antibody
-
Ab179387-100μgBAY 1158061 (anti-PRLR) is a potent monoclonal antibody, targeting prolactin (PRL) receptor. It is considered a good candidate for further development in endometriosis or other PRL-mediated disease conditions.Purity>95%